Skip to content
healthcare.dev

Tivicay PD

NDC 49702-255, dolutegravir sodium, tablet, for suspension, from ViiV Healthcare Company.

Product NDC
49702-255
Status
Listed
Labeler
ViiV Healthcare Company
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213983
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49702-255 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOLUTEGRAVIR SODIUM5 mg/1

Pharmacologic classes

HIV Integrase Inhibitors [MoA]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
49702-255-37497020255371 BOTTLE in 1 CARTON (49702-255-37) / 60 TABLET, FOR SUSPENSION in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/63df5af3-b8ac-4e76-9830-2dbb340af922

Use it

Look up 49702-255 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49702-255 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49702-255. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.